首页> 外文期刊>Radiology >Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma.
【24h】

Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma.

机译:在韩国甲状腺乳头状微癌患者中,BRAFV600E突变与不良的临床预后因素和美国特征相关。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the association of known prognostic factors with the BRAF(V600E) mutation and its association with ultrasonographic (US) features in Korean patients with papillary thyroid microcarcinoma (PTMC). MATERIALS AND METHODS: This retrospective study was institutional review board approved; informed consent was not required from patients. From July 2008 to November 2008, 339 consecutive patients underwent surgery for PTMC. US-guided fine-needle aspiration biopsy was performed to evaluate BRAF status in thyroid nodules before surgery. Logistic regression analysis was performed to assess the association between BRAF status, determined by using clinicopathologic factors, and several US features. RESULTS: Univariate analysis revealed an association between the BRAF(V600E) mutation and both tumor size and extracapsular invasion. Tumor size, extracapsular invasion, and high TNM stage (III and IV) were significantly associated with BRAF(V600E) in multivariate analysis. BRAF(V600E) was not significantly associated with any US features. CONCLUSION: The BRAF(V600E) mutation can be used as a potential prognostic factor in PTMC patients in a BRAF(V600E)-prevalent area. Future studies will be needed to determine how this information can be used to alter patient care.
机译:目的:在韩国甲状腺乳头状微癌(PTMC)患者中,评估已知预后因素与BRAF(V600E)突变的相关性及其与超声(US)特征的相关性。材料与方法:这项回顾性研究获得了机构审查委员会的批准;不需要患者的知情同意。从2008年7月至2008年11月,连续339例患者接受了PTMC手术。在手术前进行了美国指导的细针穿刺活检,以评估甲状腺结节的BRAF状态。进行逻辑回归分析以评估BRAF状态(通过使用临床病理因素确定)与几种美国特征之间的关联。结果:单因素分析显示BRAF(V600E)突变与肿瘤大小和囊外浸润之间存在关联。在多变量分析中,BRAF(V600E)与肿瘤大小,囊外浸润和高TNM分期(III和IV)显着相关。 BRAF(V600E)与美国的任何功能均没有显着关联。结论:BRAF(V600E)突变可作为BRAF(V600E)流行地区的PTMC患者的潜在预后因素。需要进行进一步的研究以确定如何将这些信息用于改变患者的护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号